Being the first and the only approved vaccine of a deadly parasitic disease makes RTS, S a potential part of malaria-control tool kit. This vaccine will help in lowering the tide of the disease-malaria...
2021
A novel immunogene CD47-targeting therapy inhibiting tumour growth
Researchers have now developed a novel therapy concept for programming the tumour cells to produce a CD47-blocking and immune-activation fusion protein in the hope that this will halt tumour growth...
A novel inhibitor of dengue virus
In a recent study conducted by researchers at the Rega Institute for Medical Research, KU Leuven, have identified and developed an ultrapotent inhibitor of the dengue virus (DENV), which causes the tropical disease known as dengue.
Variations in leukocytes – three months following mild COVID-19 infection
Researchers have investigated and described the rate of changes in peripheral blood white cells (WBCs) in individuals who have recovered from SARS-CoV-2 infection...
Insights into the development of the blood and immune systems in prenatal bone marrow
Researchers from the Wellcome Sanger Institute, Newcastle University and their collaborators have performed a comprehensive analysis of how the blood and immune systems develop in prenatal bone marrow...
New hope – a potential new treatment for sepsis
Researchers from California have identified molecular biomarkers, pathways and immune cell dynamics associated with sepsis that can be potentially targeted in order to prevent death from and develop new treatments for sepsis.
Identification of D6R and C5aR2 as key molecules with the potential to combat inflammatory diseases
Researchers have identified key molecules within the immune system that have the potential, through their use, to combat inflammation implicated in chronic diseases including COVID-19, cancers and...
Microglial cells – immune cells of the CNS breaking down harmful proteins in the brain
Researchers from the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE), and the Institut François Jacob in France have identified a mechanism describing α-syn accumulation and microglial degradation.
A new cell type contributing to inflammatory skin diseases
In an interesting discovery, an international team of researchers have identified and described a new cell type in human skin that contributes to inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis (PSO).
How does vitamin A enter our intestinal immune cells and what are the implications?
Researchers from the University of Texas Southwestern Medical Center have discovered how vitamin A enters immune cells in the intestines. Implications - improving vaccine efficacy to the potential treatment of digestive diseases.